Log in to your Inderes Free account to see all free content on this page.
OptiCept Technologies
1.88 SEK
-3.00 %
Less than 1K followers
OPTI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for OptiCept Technologies
EV/S
Median 2019-2021
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 22.48 | 52.32 | 83.01 | 10.37 | 3.88 | 4.96 | 2.56 |
| Shares | 10.9 | 12.3 | 19.4 | 19.9 | 29.6 | 62.8 | 64.8 |
| Market cap | 244.7 | 641.5 | 1,609.8 | 206.6 | 115.0 | 311.3 | 166.0 |
| Enterprise value | 231.0 | 619.4 | 1,546.2 | - | - | - | - |
| EV/S | 66.4 | 2,260.7 | 103.9 | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | - | - | - | - |
| EV/EBIT | neg. | neg. | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 10.74 | 18.34 | 3.92 | 0.52 | 0.33 | 0.86 | 0.60 |
| P/S | 70.3 | 2,341.4 | 108.2 | 19.7 | 12.6 | 17.6 | 6.1 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 90.1 % | 89.1 % | 92.3 % | 83.7 % | 90.4 % | 92.3 % | 75.6 % |
| Gearing ratio | - | - | 1.1 % | 6.8 % | 4.7 % | 4.4 % | 16.8 % |
Login required
This content is only available for logged in users